Lee Danner & Bass Inc Organon & Co. Transaction History

Lee Danner & Bass Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$23.31 - $28.61 $181,048 - $222,213	7,767 New	7,767 $217,000
Q2 2022 Jul 25, 2022	BUY	$31.66 - $38.9 $20,072 - $24,662	634 Added 7.9%	8,661 $292,000
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $12,149 - $15,704	-399 Reduced 4.74%	8,027 $280,000
Q4 2021 Jan 27, 2022	SELL	$28.67 - $37.13 $79,616 - $103,110	-2,777 Reduced 24.79%	8,426 $257,000
Q3 2021 Nov 01, 2021	BUY	$28.63 - $35.64 $5,668 - $7,056	198 Added 1.8%	11,203 $367,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $313,092 - $418,190	11,005 New	11,005 $333,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

Stay updated on Lee Danner & Bass Inc with notifications on news.